Disc Medicine, Inc. 4

COO Yu Jonathan Yen‑Wen of Disc Medicine, Inc. exercised 100 options at $13.50 and sold 100 common shares at about $82.50 on July 7, 2026 under a Rule 10b5‑1 plan.

On July 7, 2026, Disc Medicine, Inc. Chief Operating Officer Yu Jonathan Yen‑Wen exercised 100 stock options for common stock at an exercise price of $13.50 per share and simultaneously sold 100 common shares at a reported sale price of approximately $82.50 per share under a Rule 10b5‑1 trading plan adopted on March 17, 2026. The option exercise (code M) resulted in the acquisition of 100 shares at $13.50, while the market sale (code S) of 100 shares generated proceeds of about $8,250. Following these routine compensation-related transactions, which involved a very small number of shares, the reporting person beneficially owned 54,324 shares directly, representing an estimated holding value of roughly $4.48 million assuming the $82.50 sale price approximates the current market price.

Filing Facts

CIK

1816736

Ticker

IRON

Form

4

Source Type

fda

Accession

0001193125-26-299954

Alert Tier

5